Catalog Number:
UNO Peptide
UNO selectively targets Mannose Receptor (CD206/MRC1)-expressing Tumor-Associated Macrophages (TAMs), contributing to the suppression of tumor growth, angiogenesis, metastasis, and relapse. Intriguingly, FAM-labeled UNO (FAM-UNO) homes in on TAMs in various cancer models, including breast carcinoma, melanoma, glioma, and gastric carcinoma. Ex vivo organ imaging demonstrates FAM-UNO's exceptional ability to accumulate in sentinel lymph nodes, hinting at its potential in diagnostic imaging and therapeutic targeting of TAMs in solid tumors. It was found that the linear CSPGAKVRC and CSPGAK bind to CD206.
Scodeller P, Simón-Gracia L, Kopanchuk S, Tobi A, Kilk K, Säälik P, Kurm K, Squadrito ML, Kotamraju VR, Rinken A, De Palma M, Ruoslahti E, Teesalu T. Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide. Sci Rep. 2017 Nov 7;7(1):14655. doi: 10.1038/s41598-017-14709-x. PMID: 29116108; PMCID: PMC5676682.
  • 1 Units in Stock

Ask a Question


Add to Cart:
LifeTein LifeTein provides custom peptide synthesis service, recombinant proteins, peptides, cytokines, custom antibody service and custom protein service. LifeTein is the world leader in fast peptide synthesis service with lab facility located in New Jersey USA. LifeTein Peptide 100 Randolph Road, Suite 2D, Somerset USA New Jersey 08873
Copyright © 2024 LifeTein.com. Powered by LifeTein